Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Medical Device Experts

Articles with lock require a subscription to GLG News | Request a free trial
Ken PowellFebruary 22, 2008
Medical errors and patient safety
Analysis of: Managing Preanalytical Processes for Patient Safety | www.medcompare.com
Author: Ken Powell, President, Genesis Business Development
Medical errors and patient safety have become a key focus area of accrediting bodies such as Joint Commission on Accreditation of Healthcare (JACHO) and public and private payors.  One preventable cause of these errors occurs when a patient sample is collected for analysis.  This is often...
February 19, 2008
Chinese Heparin Debacle May Cause World Wide Shortage for Dialysis Providers
Analysis of: China Plant Played Role | online.wsj.com
Author: Joe Atkins, Chief Executive Officer, Medical Concepts & Innovations
Although patient deaths are of grave concern, the impact of a heparin shortage stand to put around 400,000 US dialysis patients at risk.  Heparin is the "oil of hemodialysis" and without it, hemodialysis would come to a standstill. There are alternatives available, such as Andiomax and Lovenox,...
February 4, 2008
Controversy Bred By Under-Regulation: Are Genes Too Casual?
Analysis of: Growth of Genetic Tests Concerns Federal Panel | www.nytimes.com
Author: James O'Reilly, Volunteer Professor of Law, University of Cincinnati - CC
Recent reports by a federal study panel, addressed in stories in the NY Times and other sources, highlight one more gap between expectations and reality in the resource-starved federal safety net for consumers. Much less is being done to oversee Gene Test kits than consumers may expect; eventually there...
Ken PowellJanuary 28, 2008
Inverness to Acquire Matria Healthcare for $900MM
Analysis of: Matria to merge with Inverness | biz.yahoo.com
Author: Ken Powell, President, Genesis Business Development
Inverness Medical Innovations is building a global healthcare enterprise with today's acquisition of Matria Healthcare.  This move expands Inverness beyond its point-of-care technology focus into the lucrative healthcare services area. This move further enhances Inverness's attractiveness ans...
January 25, 2008
Sustainable Cost Cutting Efforts Through Strategic Partnerships
Analysis of: Pfizer, Novartis, Amgen: cutting costs could boost short-term profits | www.pharmaceutical-business-review.com
Author: GLG Expert Contributor
In today's ever changing pharmaceutical/biotech landscape, manufacturers need to take an aggressive approach to reduce cost while developing their robust pipelines.  To do this successfully, manufacturers need to focus on their core competencies as strategically determined by the senior management...
Ken PowellJanuary 25, 2008
Colorectal Cancer
Analysis of: GeneNews Publication Confirms Blood-Based Colorectal Cancer Biomarker Results | www.genenews.com
Author: Ken Powell, President, Genesis Business Development
A new, blood-based molecular diagnostic screening test for colorectal cancer could revolutionize screening for this disease.  Third party payors would rapidly embrace and reimburse for a cost-effective way to reduce conventional screening procedures and the mortality associated with this disease....
Ken PowellJanuary 23, 2008
Roche to Acquire Ventana for $89.50 and Expands its Leadership Position in Clinical Diagnostics
Analysis of: Roche to Acquire Ventana for $89.50 per share | phx.corporate-ir.net
Author: Ken Powell, President, Genesis Business Development
Roche's (SWX: ROG.VX; RO.S; OTCQX: RHHBY) acquisition of Ventana Medical Systems Inc. (Nasdaq: VMSI) is yet another example of the rapid consolidation in the clinical diagnostics market segment.  Roche Diagnostics is the worldwide leader in the clinical diagnostics space.  The Ventana acquisition...
Ken PowellJanuary 21, 2008
Genetic Testing
Analysis of: Genetic Testing Oversight | www.aacc.org
Author: Ken Powell, President, Genesis Business Development
The rapid growth of genetic testing has prompted calls from various agencies and organizations for improved regulations of these tests by the Centers for Medicare and Medicaid Services (CMS).  Increased regulation could impact the growth and profitability of these tests.  However,...
Ken PowellJanuary 14, 2008
Sepsis
Analysis of: The quest for Faster Sepsis Diagnosis | www.aacc.org
Author: Ken Powell, President, Genesis Business Development
Sepsis is the leading cause of mortality in the United States, responsible for over 215,000 deaths per year.   While sepsis sometimes arises from an infection in an otherwise healthy person, all hospital patients are at risk. But identifying patients with sepsis is difficult because its...
Ken PowellJanuary 14, 2008
MRSA Investment Opportunities
Analysis of: MRSA | biz.yahoo.com
Author: Ken Powell, President, Genesis Business Development
MRSA continues to be top major problem plaguing global healthcare systems.  Several companies are working to provide innovative, cost-effective solutions to combat this drug resistant disease that costs the US healthcare system over $30 billion each year.  As more companies enter...

Previous Page : 1 2 3 4 5 6 7 8 9 10 11 12 13 Next51 to 60 of 122

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-02T09:45:16.440